Green Tea Extract and Prostate Cancer
Completed · Phase 2
Conditions studied: Prostate Cancer
In brief
The purpose of the study is to see if a green tea extract can beneficially alter several markers of cancer risk and progression.
Key facts
- Study ID
- NCT00676780
- Run by
- Louisiana State University Health Sciences Center Shreveport
- People needed
- 33
- Starts
- 2004-05-01
- Expected to finish
- 2008-12-01
- Last updated by the study team
- 2012-08-08
Who can join
Age: 18 and older, up to 75. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- recent biopsy positive for prostate cancer
- scheduled for prostatectomy
- must be able to swallow capsules
- Palpable mass by digital rectal examination (DRE)
- Ability to give informed consent and willingness to adhere to study protocol
- Age ≥ 18 years and less than 75
You may not qualify if…
- abnormal liver function
- Prior hormonal or surgical therapy for prostate cancer
- Liver or kidney problems that would interfere with metabolism of study drug
- Any condition that would hamper informed consent or ability to comply with study protocol
- Participation in another research study in the last three months
- Known malignancy at any site other than prostate
- Recent consumption of green tea (5 or more cups per day, within one week prior to biopsy)
Where it is running
- LSU Health Sciences Center — Shreveport, Louisiana, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.